Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

CMPS COMPASS Pathways PLC

8,06

0,07 (0,88%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

COMPASS Pathways (NASDAQ:CMPS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more COMPASS Pathways Charts.

COMPASS Pathways (NASDAQ:CMPS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more COMPASS Pathways Charts.

News COMPASS Pathways PLC

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
Mittwoch 8 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 8 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder
Mittwoch 8 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
Donnerstag 2 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Weitere COMPASS Pathways PLC News-Artikel

Bespoke Extracts (QB)

GlobeCoin Token

BMO MSCI Europe High Qua...

Vontobel Financial Produ...

Republic of France 0.5% ...

Seritage Growth Properties

Govhongkong 26a

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen